TPG Capital Offers $1.97B for diagnostic Company focused in blood donor screening.
TPG Capital is a private equity firm with $48B in assets.
Immucor was added to the Rayno Life Science Portfolio in April 2010 at a price of $20.
TPG Capital Offers $1.97B for diagnostic Company focused in blood donor screening.
TPG Capital is a private equity firm with $48B in assets.
Immucor was added to the Rayno Life Science Portfolio in April 2010 at a price of $20.